[1]马文超,陈薇,付蔷,等.腹膜弥漫性病变的18F-FDG PET/CT诊断辨析[J].国际放射医学核医学杂志,2018,(2):192-195.[doi:10.3760/cma.j.issn.1673-4114.2018.02.018]
　Ma Wenchao,Chen Wei,Fu Qiang,et al.Differential diagnosis and analysis of diffuse peritoneal lesions by 18F-FDG PET/CT[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(2):192-195.[doi:10.3760/cma.j.issn.1673-4114.2018.02.018]
点击复制

腹膜弥漫性病变的18F-FDG PET/CT诊断辨析(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
期数:
2018年第2期
页码:
192-195
栏目:
疑难病案分析
出版日期:
2018-05-09

文章信息/Info

Title:
Differential diagnosis and analysis of diffuse peritoneal lesions by 18F-FDG PET/CT
作者:
马文超;  陈薇;  付蔷;  宋秀宇;  朱磊;  朱湘;  张利卜;  徐文贵
300060, 天津医科大学肿瘤医院分子影像及核医学诊疗科
Author(s):
Ma Wenchao;  Chen Wei;  Fu Qiang;  Song Xiuyu;  Zhu Lei;  Zhu Xiang;  Zhang Libo;  XuWengui
Department of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
DOI:
10.3760/cma.j.issn.1673-4114.2018.02.018
摘要:
腹膜弥漫性病变分为炎性和肿瘤性两类，前者以结核性腹膜炎最为常见，后者以转移瘤最为多见，其次较为多见的是腹膜原发肿瘤，包括腹膜癌、间皮瘤、淋巴瘤等。对腹膜弥漫性病变的鉴别诊断一直是临床工作的难点。由于腹膜弥漫性病变涉及病种多，影像学表现也极为复杂多变，因此笔者选取两例常见类别的腹膜弥漫性病变：腹膜结核和腹膜癌，分别从临床特点及18F-FDG PET/CT影像学特征等方面进行诊断辨析，总结分析诊断思路，为得出准确的临床诊断提供帮助。
Abstract:
Diffuse peritoneal lesions can be divided into two types, that include inflammatory and neoplastic diseases. The most common form of the former is tuberculous peritonitis. The most common malignant disease of peritoneal is metastatic tumor, followed by primary peritoneal tumors including peritoneal cancer, mesothelioma and lymphoma. Its differential diagnosis has been difficult in clinical work due to diffuse peritoneal lesions involve multiple kinds of diseases and their imaging features are extremely complex. The author selected two common cases of diffuse peritoneal lesions, which are tuberculosis of peritoneum and primary peritoneal cancer. We analyzed their clinical characteristics and imaging features of 18F-FDG PET/CT, in order to help with diagnosis and differentiation of the diffuse peritoneal lesions in clinical practice.

参考文献/References:

[1] Yin WJ, Zheng GQ, Chen YF, et al. CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis[J]. Radiol Med, 2016, 121(4):253-260. DOI:10.1007/s11547-015-0609-y.
[2] 李现军, 李凤岐, 韩建奎, 等. 18F-FDG PET/CT检査中腹腔积液SUV对不明原因腹腔积液的辅助诊断价值[J]. 中华核医学与分子影像杂志, 2013, 33(6):421-425. DOI:10.3760/cma.j.issn.2095-2848.2013.06.005. Li XJ, Li FQ, Han JK,et al. The role of standardized uptake value in 18F-FDG PET/CT for auxiliary diagnosis of ascites with unknown cause[J]. Chin J Nucl Med Mol Imaging, 2013, 33(6):421-425.
[3] 王春辉, 王晶. 卵巢外腹膜浆液性乳头状癌诊疗进展[J]. 现代肿瘤医学, 2015(7):998-1001. DOI:10.3969/j.issn.1672-4992. 2015. 07.34. Wang CH, Wang J. Diagnosis and the latest progress about extraovarian peritoneal serous carcinoma[J]. J Mod Oncol, 2015(7):998-1001.
[4] 陈华, 黄建瑾. 原发性腹膜癌病因及治疗进展[J]. 中国实用妇科与产科杂志, 2006, 22(6):466-468. DOI:10.3969/j.issn.1005-2216.2006.06.029. Chen H, Huang JJ. The etiology and treatment progress of primary peritoneal carcinoma[J]. Chin J Pract Gynecol Obste, 2006, 22(6):466-468.
[5] 皮亚平, 田柳. 肿瘤标志物CA153、CA125联合检查对乳腺癌诊断的价值分析[J]. 实用癌症杂志, 2017, 32(8):1351-1353. DOI:10.3969/j.issn.1001-5930.2017.08.039. Pi YP, Tian L. Value of Combined Examination of Tumor Markers CA125 and CA153 in the Diagnosis of Breast Cancer[J]. Pract J Cancer, 2017, 32(8):1351-1353.
[6] 胡望平, 叶桂云, 池细俤, 等. CA153等在乳腺癌肺癌及几种疾病中的应用[J].中国实验诊断学, 2007, 11(6):772-775. DOI:10.3969/j.issn.1007-4287.2007.06.023. Hu WP, Ye GY, Chi XD, et al. Application of CA153 assay for breast cancer and pulmonary carncinoma and so on malignant and benign diseases[J]. Chin J Laboratory Diagnosis, 2007, 11(6):772-775.
[7] 王菲, 狄丽平, 赵宁, 等. 不同化疗方式联合手术治疗中晚期宫颈癌的临床研究[J]. 饮食保健, 2016, 3(19):24. Wang F, Di LP, Zhao N, et al. The clinical research of middle-advanced cervical carcinoma treated by different chemotherapy combined with operation[J]. Diet Health, 2016, 3(19):24.
[8] Emoto S, Ishigami H, Yamashita H, et al. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination[J]. Gastric Cancer, 2012, 15(2):154-161. DOI:10.1007/s10120-011-0091-8.

备注/Memo

备注/Memo:
收稿日期:2018-01-27。
通讯作者:徐文贵,Email:wenguixy@163.com
更新日期/Last Update: 2018-05-09